Legal & General Group
DNTH icon

Legal & General Group’s Dianthus Therapeutics DNTH Stock Holding History

Legal & General Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
21,627
+8,037
+59% +$465K ﹤0.01% 1951
2025
Q4 		$560K Buy
13,590
+12,093
+808% +$469K ﹤0.01% 2396
2025
Q3 		$58.9K Sell
1,497
-332
-18% -$8.48K ﹤0.01% 2699
2025
Q2 		$34.1K Sell
1,829
-2,062
-53% -$38.7K ﹤0.01% 2807
2025
Q1 		$70.6K Sell
3,891
-8,428
-68% -$186K ﹤0.01% 2693
2024
Q4 		$269K Buy
12,319
+2,363
+24% +$60.8K ﹤0.01% 2626
2024
Q3 		$273K Buy
9,956
+1,902
+24% +$53K ﹤0.01% 2628
2024
Q2 		$207K Buy
+8,054
New +$194K ﹤0.01% 2660
2022
Q3 		– Sell
-149
Closed -$3K – 3464
2022
Q2 		$3K Sell
149
-44
-23% -$1.09K ﹤0.01% 3474
2022
Q1 		$9K Hold
193
– – ﹤0.01% 3422
2021
Q4 		$14K Hold
193
– – ﹤0.01% 3378
2021
Q3 		$22K Hold
193
– – ﹤0.01% 3242
2021
Q2 		$30K Buy
193
+52
+37% +$9.55K ﹤0.01% 3132
2021
Q1 		$27K Sell
141
-12
-8% -$2.02K ﹤0.01% 3021
2020
Q4 		$19K Hold
153
– – ﹤0.01% 3107
2020
Q3 		$17K Sell
153
-14
-8% -$1.66K ﹤0.01% 3019
2020
Q2 		$20K Sell
167
-39
-19% -$5.5K ﹤0.01% 3065
2020
Q1 		$21K Sell
206
-45
-18% -$8.34K ﹤0.01% 2888
2019
Q4 		$61K Buy
251
+48
+24% +$8.97K ﹤0.01% 2741
2019
Q3 		$33K Hold
203
– – ﹤0.01% 2916
2019
Q2 		$48K Buy
203
+51
+34% +$12.6K ﹤0.01% 2789
2019
Q1 		$40K Buy
152
+109
+253% +$18.8K ﹤0.01% 2787
2018
Q4 		$4K Hold
43
– – ﹤0.01% 3350
2018
Q3 		$8K Buy
+43
New +$9.05K ﹤0.01% 3342

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Legal & General Group's DNTH Position: Q1 2026 in Review

Legal & General Group increased its Dianthus Therapeutics (DNTH) stake by 59% in Q1 2026, buying an estimated $465K and bringing the position to 21,627 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

Legal & General Group first reported a position in DNTH in Q3 2018 and has held it in 24 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Legal & General Group held 21,627 shares of Dianthus Therapeutics worth $1.81M as of Q1 2026.
  • Legal & General Group bought 8,037 Dianthus Therapeutics shares in Q1 2026, an estimated $465K.
  • Dianthus Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1951 holding.
  • Legal & General Group first reported a position in Dianthus Therapeutics in Q3 2018 and has held it in 24 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.